Terms: = Bone cancer AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1 AND Prognosis
5543 results:
1. Preoperative abnormal bone mineral density as a prognostic indicator in patients undergoing gastrectomy for gastric cancer: A cohort study.
An S; Eo W
Medicine (Baltimore); 2024 May; 103(21):e38251. PubMed ID: 38788023
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
[TBL] [Abstract] [Full Text] [Related]
3. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
5. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
6. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
Dang J; Xu G; Guo G; Zhang H; Shang L
J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
8. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
[No Abstract] [Full Text] [Related]
9. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract] [Full Text] [Related]
10. bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors.
Lou J; Gong B; Li Y; Guo Y; Li L; Wang J; Liu W; You Z; Zhang H; Pan F; Liang B; Yang L; Zhou G
Front Immunol; 2024; 15():1332303. PubMed ID: 38698843
[TBL] [Abstract] [Full Text] [Related]
11. Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma.
Zheng J; Wang Q; Chen J; Cai G; Zhang Z; Zou H; Zou JX; Liu Q; Ji S; Shao G; Li H; Li S; Chen HW; Lu L; Yuan Y; Liu P; Wang J
Cell Rep Med; 2024 May; 5(5):101519. PubMed ID: 38692271
[TBL] [Abstract] [Full Text] [Related]
12. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
[TBL] [Abstract] [Full Text] [Related]
13. [Obesity and risk of relapse in patients with Acute Lymphoblastic Leukemia: A retrospective study].
Ramos-Peñafiel CO; Bejarano-Rosales MP; Gallardo-Rodríguez AG; Pérez-Sámano D; Leyton-Rivera HR; Olarte-Carrillo I; Martínez-Tovar A; Tarlovsky VF; Barranco-Lampón G; Alvarez-Altamirano K
Rev Med Chil; 2023 May; 151(5):600-609. PubMed ID: 38687542
[TBL] [Abstract] [Full Text] [Related]
14. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract] [Full Text] [Related]
15. The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract] [Full Text] [Related]
16. [Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].
Yuan Q; Han YL; Pan C; Tang JY; Gao YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):365-370. PubMed ID: 38660900
[TBL] [Abstract] [Full Text] [Related]
17. Upregulation of circ_0076684 in osteosarcoma facilitates malignant processes by mediating miRNAs/CUX1.
Cai P; Fu X; Li X; Zhao W
J Orthop Surg Res; 2024 Apr; 19(1):260. PubMed ID: 38659042
[TBL] [Abstract] [Full Text] [Related]
18. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
[No Abstract] [Full Text] [Related]
19. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
20. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
Long Q; Li Z; Yang W; Huang K; Du G
J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
[TBL] [Abstract] [Full Text] [Related]
[Next]